Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers

This research study is studying the effect of different drugs as possible treatments for salivary and other head and neck cancers/ The name of the study intervention involved in this study is: \-- implantable microdevice

Trial Details

NCT ID

NCT05553782

Phase

EARLY_PHASE1

Sponsor

Brigham and Women's Hospital

Status

RECRUITING

Cancer Type

Salivary Gland Head and Neck Cancer

Interventions

Implantable Microdevice (IMD)

Locations (sample)

Boston, Massachusetts, United States|42.35843,-71.05977
Boston, Massachusetts, United States|42.35843,-71.05977

Key Eligibility Criteria

Participants must have histologically confirmed head and neck cancer (salivary or ACC type, or squamous cell carcinoma) without evidence of recurre…
Age 18 years or older.
Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1.
A measurable primary tumor site both clinically and radiologically measuring at least 1 x 1 cm.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Salivary Gland Head and Neck Cancer Trials on Trialify →